Leukemia patients try life without daily pills in groundbreaking 'Drug Holiday' study

NCT ID NCT04626024

First seen Jan 06, 2026 · Last updated Apr 07, 2026 · Updated 15 times

Summary

This study is testing whether some patients with a type of leukemia called CML, who have been in a very deep remission for years while taking daily TKI pills, can safely stop taking those pills and stay in remission. Researchers will monitor 100 patients closely after they stop their medication to see if the cancer returns and to understand who is most likely to succeed without the drugs. The goal is to allow eligible patients to live free from daily medication and its side effects and costs, if it is safe to do so.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baylor College of Medicine- McNair Campus

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ben Taub General Hospital

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHI St. Luke's Health Baylor College of Medicine Medical Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Harris Health System- Smith Clinic

    RECRUITING

    Houston, Texas, 77054, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.